![]() |
|
|
Vol. 281, Issue 1, 155-162, 1997
Departments of
Pharmacology (E.P.) and
Medicine (E.P., B.J.S.,
R.L.), College of Medicine, University of Oklahoma Health Sciences
Center, Oklahoma City, Oklahoma,
Research Service (E.P., B.J.S.),
Department of Veterans Affairs Medical Center, Oklahoma City, Oklahoma
and Departments of
Pharmacology (S.S.) and
Chemistry (G.L.G., K.M.C.,
K.D.B.), Oklahoma State University, Stillwater, Oklahoma
The electrophysiologic effects of the imidazole-substituted
diheterabicyclo[3.3.1]nonane compounds GLG-V-13 and KMC-IV-84 were
evaluated in canine ventricular tissues using intracellular and
extracellular recordings. The drugs produced a concentration-dependent prolongation of action potential duration at 90% of repolarization in
Purkinje (338 ± 26 to 611 ± 43 msec, 10 mg/l GLG-V-13;
328 ± 17 to 468 ± 18 msec, 10 mg/l KMC-IV-84), in right
ventricular subendocardium (260 ± 18 to 335 ± 18 msec, 10 mg/l GLG-V-13; 221 ± 9 to 264 ± 13 msec, 10 mg/l KMC-IV-84)
and in left ventricular epicardium (195 ± 13 to 256 ± 18 msec, 10 mg/l GLG-V-13; 203 ± 11 to 273 ± 26 msec, 10 mg/l
KMC-IV-84) without altering resting membrane potential, action
potential amplitude, overshoot potential, Vmax, conduction
velocity or Purkinje fiber automaticity. Prolongation of the effective
refractory period was proportional to the change in action potential
duration at 90% of repolarization. Prolongation of action potential
duration at 90% of repolarization was maximal at paced cycle lengths
exceeding 1000 msec and was minimal at a paced cycle length of 250 msec
(Purkinje: 266 ± 20 vs. 6 ± 8 msec, GLG-V-13;
178 ± 12 vs. 10 ± 10 msec, KMC-IV-84. Right
ventricular subendocardium: 70 ± 12 vs. 10 ± 2 msec, GLG-V-13; 60 ± 8 vs. 19 ± 6 msec. Left
ventricular epicardium: 67 ± 13 vs. 10 ± 5 msec, GLG-V-13; 68 ± 12 vs. 16 ± 8 msec, KMC-IV-84).
An increase in K+o to 12 mM reduced action
potential prolongation by GLG-V-13 and KMC-IV-84 in left ventricular
epicardium. The results demonstrate selective class III
electrophysiologic properties for imidazole-substituted diheterabicyclo[3.3.1]nonane compounds.